MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0009319
BR Biologics Private Limited
BR Biologics Private Limited - real estate and construction in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.69 Lakh
▲ 145% YoY
Net profit · FY 2025
₹62,642
Net margin 4%
EBITDA · FY 2025
₹1.22 Lakh
EBITDA margin 7.8%
Authorised capital
₹2.25 Cr
Registered with MCA
Paid-up capital
₹2.25 Cr
Issued & subscribed
Satisfied charges
₹5 Lakh
No open charges
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
About BR Biologics Private Limited
Data last updated:
BR Biologics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the real estate marketing and sales segment of the real estate and construction sector. It was incorporated on 26 February 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74220DL1998PTC092443. Its GSTIN is 06AAACB6319A3Z9 (Haryana). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.25 Cr and a paid-up capital of ₹2.25 Cr. It is led by directors Bhushan Kumar Chawla and Surinder Pal Chawla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 416 Ground Floor Bhera Enclave Paschim Vihar, New Delhi, Delhi, India – 110087.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.69 Lakh, a growth of 145% compared to the previous year. For the same year it recorded a net profit of ₹62,642 (net margin 4%) and EBITDA of ₹1.22 Lakh (EBITDA margin 7.8%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 27% over five years.
As per MCA filings, the company has satisfied charges of ₹5 Lakh on record.
BR Biologics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0009319). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74220DL1998PTC092443
Registration Number 092443
Incorporation Date 26 February 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0009319
Recognitions & Rankings of BR Biologics
Contact details
BR Biologics Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address416 Ground Floor Bhera Enclave Paschim Vihar, New Delhi, Delhi, India – 110087
- IndustryReal Estate and Construction, Real Estate Marketing & Sales, Real Estate Builders & Developers
To see the full contact details of BR Biologics Private Limited, buy the company report.
Comprehensive company report
BR Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of BR Biologics is construction. In detail, this covers construction of buildings.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| F | Construction | 41 | Construction of buildings |
To see the full business activity and turnover split of BR Biologics Private Limited, buy the company report.
Financials of BR Biologics Private Limited
FY 2025 filings availableBR Biologics Private Limited reported revenue of ₹15.69 Lakh (up 145% YoY) for FY 2025.
Revenue · FY 2025
₹15.69 Lakh ▲ 145%
Net profit · FY 2025
₹62,642 margin 4%
EBITDA · FY 2025
₹1.22 Lakh margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 145%
3 years · compounded
▼ 16%
5 years · compounded
▼ 27%
EBITDA CAGR growth
1 year
▼ 39%
3 years · compounded
▼ 27%
5 years · compounded
▼ 27%
Revenue rose 145% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 27%. EBITDA fell 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62,642 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of BR Biologics Private Limited, buy the company report.
Board of directors of BR Biologics Private Limited
BR Biologics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhushan Kumar Chawla Also directs: Calico Polymers Private Limited, Barkat Raj Infra Private Limited, Kismat Buildcon Private Limited and 2 more | Director | 01 Feb 2021 | 5 Years 9 Months | Current |
| Surinder Pal Chawla Also directs: Calico Polymers Private Limited, Barkat Raj Infra Private Limited, Kismat Buildcon Private Limited and 2 more | Director | 08 Feb 2021 | 5 Years 9 Months | Current |
Auditor
BR Biologics Private Limited is audited by U SHANKER & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| U SHANKER & ASSOCIATES | FY 2020 | 014497N |
Shareholding
The shareholding of BR Biologics Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of BR Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹5 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Nov 2003 | 90055114 | State Bank of Mysoore | ₹5 Lakh | Satisfied |
To see the full charge records of BR Biologics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving BR Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for BR Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
BR Biologics has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACB6319A3Z9 | Haryana | Active | 06 Mar 2021 |
To see the full GST registrations and return filing status of BR Biologics Private Limited, buy the company report.
Recent activity
BR Biologics Private Limited has 6 board changes on record since 2000: 4 appointments and 2 cessations. The latest: Sameer Chawla ceased to be Director on 08 Feb 2021.
AGM
Br Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Br Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge registered on 27 Nov 2003 via Charge ID 90055114 with State Bank Of Mysoore was fully satisfied on 07 Jul 2021.
Ceased
Sameer Chawla ceased to be Director.
Appointed
Surinder Pal Chawla was appointed as Director.
Appointed
Bhushan Kumar Chawla was appointed as Director.
Ceased
Pankaj Chawla ceased to be Director.
Charges
A charge with State Bank Of Mysoore of Rs. 0.05 Cr registered on 27 Nov 2003 with Charge ID 90055114 was modified on 08 Mar 2004.
Charges
A charge with State Bank Of Mysoore amounted to Rs. 0.05 Cr with Charge ID 90055114 was registered on 27 Nov 2003.
Appointed
Pankaj Chawla was appointed as Director.
Appointed
Sameer Chawla was appointed as Director.
Incorporation
26 Feb 1998
Br Biologics Private Limited was registered on 26 Feb 1998 with Roc Delhi Ii & aged 28 years 8 months as per MCA records.
Frequently asked questions
BR Biologics is an active private limited company based in New Delhi, Delhi, India. The company works in real estate marketing and sales, within the real estate and construction industry. It was incorporated on 26 February 1998 (28+ years old) and is registered under CIN U74220DL1998PTC092443.
BR Biologics has 2 current directors:
- Bhushan Kumar Chawla - Director
- Surinder Pal Chawla - Director
The latest financial statements of BR Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of BR Biologics is 06AAACB6319A3Z9, registered in Haryana. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of BR Biologics is U74220DL1998PTC092443. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
BR Biologics was incorporated on 26 February 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Sameer Chawla ceased to be Director on 08 Feb 2021. Surinder Pal Chawla was appointed as Director on 08 Feb 2021. Bhushan Kumar Chawla was appointed as Director on 01 Feb 2021. BR Biologics has 6 board changes on record in total.
Yes, BR Biologics is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0009319).
The registered office of BR Biologics is at 416 Ground Floor Bhera Enclave Paschim Vihar, New Delhi, Delhi, India – 110087.
BR Biologics operates in the real estate and construction industry, in the real estate marketing and sales segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages